Neoadjuvant gemcitabine and cisplatin: another step on the path toward improving the outcomes of patients with high-risk, invasive bladder cancer
- PMID: 18823035
- DOI: 10.1002/cncr.23849
Neoadjuvant gemcitabine and cisplatin: another step on the path toward improving the outcomes of patients with high-risk, invasive bladder cancer
Comment on
-
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.Cancer. 2008 Nov 1;113(9):2471-7. doi: 10.1002/cncr.23848. Cancer. 2008. PMID: 18823036 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
